Literature DB >> 23109645

Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.

Dimitrios Panidis1, Konstantinos Tziomalos, Panagiotis Chatzis, Efstathios Papadakis, Dimitrios Delkos, Elena A Tsourdi, Eleni A Kandaraki, Ilias Katsikis.   

Abstract

OBJECTIVE: Insulin resistance (IR) is frequent in polycystic ovary syndrome (PCOS) and contributes to the increased risk for type 2 diabetes mellitus and cardiovascular disease of this population. Several markers of IR are used but most are expensive or have limited sensitivity and specificity. Preliminary data suggest that the menstrual cycle pattern correlates with IR in PCOS but existing studies are small. We aimed to assess the relationship between the type of menstrual cycle irregularities and IR in PCOS.
DESIGN: Prospective study.
METHODS: We studied 1285 women with PCOS, divided according to the menstrual cycle pattern.
RESULTS: Patients with isolated secondary amenorrhea and those with secondary amenorrhea alternating with regular menstrual cycles were more insulin resistant than patients with regular cycles (Group D). Patients with isolated oligomenorrhea were also more insulin resistant than Group D. However, patients with oligomenorrhea alternating with regular cycles, secondary amenorrhea, or polymenorrhea had comparable levels of markers of IR with Group D. Moreover, patients with oligomenorrhea alternating with regular cycles were less insulin resistant than patients with secondary amenorrhea alternating with regular cycles. Finally, patients with isolated polymenorrhea and those with polymenorrhea alternating with regular cycles had comparable levels of markers of IR with Group D.
CONCLUSIONS: Amenorrhea is associated with more pronounced IR in PCOS, and oligomenorrhea portends a less excessive risk for IR than amenorrhea whereas polymenorrhea appears to be even more benign metabolically. Therefore, the type of menstrual cycle abnormality appears to represent a useful tool for identifying a more adverse metabolic profile in PCOS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23109645     DOI: 10.1530/EJE-12-0655

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.

Authors:  Miro Šimun Alebić; Nataša Stojanović; Dinka Pavičić Baldani; Lea Smirčić Duvnjak
Journal:  Endocrine       Date:  2016-08-03       Impact factor: 3.633

2.  Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study.

Authors:  Michelle L Meyer; Daniela Sotres-Alvarez; Anne Z Steiner; Larry Cousins; Gregory A Talavera; Jianwen Cai; Martha L Daviglus; Laura R Loehr
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

3.  Comparing the Effects of Agnugol and Metformin on Oligomenorrhea in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial.

Authors:  Arezoo Shayan; Seyedeh Zahra Masoumi; Fatemeh Shobeiri; Shahin Tohidi; Arash Khalili
Journal:  J Clin Diagn Res       Date:  2016-12-01

4.  Impact of yoga and exercises on polycystic ovarian syndrome risk among adolescent schoolgirls in South India.

Authors:  Valarmathi Selvaraj; Jain Vanitha; Fabiola M Dhanaraj; Prema Sekar; Anitha Rajendra Babu
Journal:  Health Sci Rep       Date:  2020-12-04

5.  Menstrual Cycle Irregularity and Metabolic Disorders: A Population-Based Prospective Study.

Authors:  Marzieh Rostami Dovom; Fahimeh Ramezani Tehrani; Shirin Djalalinia; Leila Cheraghi; Samira Behboudi Gandavani; Fereidoun Azizi
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

Review 6.  Reproductive Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Fahimeh Ramezani Tehrani; Samira Behboudi-Gandevani; Marzieh Rostami Dovom; Maryam Farahmand; Sonia Minooee; Mahsa Noroozzadeh; Mina Amiri; Sima Nazarpour; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2018-10-20

7.  Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes.

Authors:  Gulay Simsek Bagir; Okan S Bakiner; Emre Bozkirli; Gulhan Cavlak; Hulya Serinsoz; M Eda Ertorer
Journal:  Med Princ Pract       Date:  2015-10-29       Impact factor: 1.927

8.  Prevalence of oligomenorrhea among women of childbearing age in China: A large community-based study.

Authors:  Yilei He; Danni Zheng; Wei Shang; Xiaohong Wang; Shuyun Zhao; Zhaolian Wei; Xueru Song; Xiaobo Shi; Yimin Zhu; Shuyu Wang; Rong Li; Jie Qiao
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.